Work Area: Licensing

Alarm bells were recently set ringing about the future of public IP company (PIPCO) Inventergy when the following paragraph appeared on page 14 of its annual report:Our ability to continue as a going concern is dependent upon our ability to…

17 April 2015

Earlier this week, IAM reported on Philips' sale of the majority of its LED lighting unit Lumileds to a Chinese-led investment consortium. The deal - which is expected to complete during the third quarter of this year, subject to conditions and…

17 April 2015

Nokia has not been far from the business pages in recent days with news first breaking that it was considering a sale of its maps business and then, this week, that it is in merger talks with Alcatel-Lucent. As both companies have undergone…

14 April 2015

Boris Teksler – current senior executive vice president and president of the Technology Business Group at Technicolor – has been appointed chief executive officer at Nevada-based NPE Unwired Planet. He will take up his new position on 1st June.…

14 April 2015

Ericsson and Nokia have told IAM that they will not be making licensing commitments under the new patent policy introduced by the Institute of Electrical and Electronics Engineers (IEEE). The moves, which follow similar announcements by Qualcomm and…

10 April 2015

Gerard Pannekoek, the president and CEO of Intellectual Property Exchange International (IPXI), has blamed its recent demise on a US patent system that inhibits good faith licensing negotiations and encourages potential licensees to shun talks until…

07 April 2015

This blog is littered with stories of a patent licensing market that often fails to provide an effective route to monetisation and ends up with people who should be making deals heading to court. And if you’re an inventor trying to get a return on a…

06 April 2015

Last 5th November, James Bessen and Michael Meurer wrote an article for the Boston Globe in which they claimed that patent trolls sponsored by foreign governments were emerging as a serious threat to American businesses; and that this was another…

05 April 2015

Suzhou-based biopharmaceuticals firm Innovent Biologics has entered into an alliance with Eli Lilly & Co which will see its cancer therapies developed and marketed worldwide by the US company in a deal potentially worth upwards of $456 million.…

02 April 2015

Issue 71 of IAM has been published online and is available for subscribers to view.The cover story focuses on the uneasy relationship that Japanese companies have with IP monetisation. Although they have built some of the world’s biggest patent…

01 April 2015